{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:20Z","timestamp":1792644080761,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022QH015"],"award-info":[{"award-number":["ZR2022QH015"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504573"],"award-info":[{"award-number":["82504573"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204196"],"award-info":[{"award-number":["82204196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119307","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:34:21Z","timestamp":1788676461000},"page":"119307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-guided discovery of HIV-1 capsid inhibitors: From diverse binding sites to resistance-resilient antiviral strategies"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6823-170X","authenticated-orcid":false,"given":"Yuyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-613X","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119307_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2796.2007.01910.x","article-title":"The first post modern pandemic: 25 years of HIV\/AIDS","volume":"263","author":"Kallings","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejmech.2026.119307_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2016.03.004","article-title":"Current status and prospects of HIV treatment","volume":"18","author":"Cihlar","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119307_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cell.2020.03.005","article-title":"Curing HIV: seeking to target and clear persistent infection","volume":"181","author":"Margolis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119307_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.medcli.2023.12.007","article-title":"Epidemiology, treatment and prognosis of HIV infection in 2024: a practical review","volume":"162","author":"de la Mora","year":"2024","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.ejmech.2026.119307_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: the multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119307_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12977-021-00583-z","article-title":"Rotten to the core: antivirals targeting the HIV-1 capsid core","volume":"18","author":"McFadden","year":"2021","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2026.119307_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coviro.2021.03.005","article-title":"Integrative structural biology of HIV-1 capsid protein assemblies: combining experiment and computation","volume":"48","author":"Perilla","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119307_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/v13030417","article-title":"Interactions of HIV-1 capsid with host factors and their implications for developing novel therapeutics","volume":"13","author":"Zhuang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/v12090940","article-title":"HIV-1 maturation: lessons learned from inhibitors","volume":"12","author":"Kleinpeter","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjad076","article-title":"The capsid revolution","volume":"15","author":"Taylor","year":"2024","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119307_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/v13010125","article-title":"HIV capsid and integration targeting","volume":"13","author":"Engelman","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib12","first-page":"100","article-title":"Structure, function, and interactions of the HIV-1 capsid protein","volume":"11","author":"Rossi","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ejmech.2026.119307_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12977-021-00566-0","article-title":"The HIV-1 capsid and reverse transcription","volume":"18","author":"Aiken","year":"2021","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2026.119307_bib14","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/v13112237","article-title":"Disassembling the nature of capsid: biochemical, genetic, and imaging approaches to assess HIV-1 capsid functions","volume":"13","author":"Ingram","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.652486","article-title":"HIV-1 capsid core: a bullet to the heart of the target cell","volume":"12","author":"Toccafondi","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119307_bib16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/v13081425","article-title":"The role of capsid in HIV-1 nuclear entry","volume":"13","author":"Guedan","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/v16091423","article-title":"Exploring HIV-1 maturation: a new frontier in antiviral development","volume":"16","author":"McGraw","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib18","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.3390\/ijms26125819","article-title":"New advances in Anti-HIV-1 strategies targeting the assembly and stability of capsid protein","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119307_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/ijms26020495","article-title":"Cyclophilin a regulates tripartite motif 5 alpha restriction of HIV-1","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119307_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/v13020246","article-title":"Visualizing HIV-1 capsid and its interactions with antivirals and host factors","volume":"13","author":"Wilbourne","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12977-021-00577-x","article-title":"HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules","volume":"18","author":"Saito","year":"2021","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2026.119307_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe4716","article-title":"A stable immature lattice packages IP6 for HIV capsid maturation","volume":"7","author":"Mallery","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119307_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt7818","article-title":"Kinetic implications of IP6 anion binding on the molecular switch of HIV-1 capsid assembly","volume":"11","author":"Gupta","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119307_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148302","article-title":"Hexakisphosphate (IP6) potentiates HIV-1 maturation inhibitor binding at the CA-SP1 junction: insights from molecular modeling and biophysical assays","volume":"330","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119307_bib25","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1038\/s41467-025-63363-9","article-title":"Structural basis for HIV-1 capsid adaption to a deficiency in IP6 packaging","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119307_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009164","article-title":"A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid assembly","volume":"17","author":"Renner","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119307_bib27","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1038\/s41467-024-51971-w","article-title":"HIV-1 adapts to lost IP6 coordination through second-site mutations that restore conical capsid assembly","volume":"15","author":"Kleinpeter","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119307_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35335","article-title":"IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis","volume":"7","author":"Mallery","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119307_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bpj.2024.12.016","article-title":"IP6 and PF74 affect HIV-1 capsid stability through modulation of hexamer-hexamer tilt angle preference","volume":"124","author":"Garza","year":"2025","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2026.119307_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01158-24","article-title":"Essential functions of inositol hexakisphosphate (IP6) in murine leukemia virus replication","volume":"15","author":"Biswas","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119307_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001220","article-title":"HIV capsid is a tractable target for small molecule therapeutic intervention","volume":"6","author":"Blair","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119307_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.aaa5936","article-title":"STRUCTURAL VIROLOGY. X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability","volume":"349","author":"Gres","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119307_bib33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JVI.01406-10","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization","volume":"85","author":"Shi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119307_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112427","article-title":"Chemical profiling of HIV-1 capsid-targeting antiviral PF74","volume":"200","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112085","article-title":"Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities","volume":"190","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.apsb.2020.07.016","article-title":"Novel PF74-like small molecules targeting the HIV-1 capsid protein: balance of potency and metabolic stability","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119307_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113903","article-title":"Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability","volume":"227","author":"Xu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib38","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acs.jmedchem.0c00015","article-title":"Design, synthesis, and mechanism study of benzenesulfonamide-containing phenylalanine derivatives as novel HIV-1 capsid inhibitors with improved antiviral activities","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib39","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.1021\/acs.jmedchem.3c01647","article-title":"Discovery, crystallographic studies, and mechanistic investigations of novel phenylalanine derivatives bearing a quinazolin-4-one scaffold as potent HIV capsid modulators","volume":"66","author":"Xu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/v13030479","article-title":"Design, synthesis and characterization of HIV-1 CA-targeting small molecules: conformational restriction of PF74","volume":"13","author":"Sahani","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29594","article-title":"Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability","volume":"96","author":"Jiang","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2026.119307_bib42","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1002\/jmv.28064","article-title":"Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein","volume":"94","author":"Jiang","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2026.119307_bib43","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.3390\/molecules27217640","article-title":"Design, synthesis, and mechanistic study of 2-pyridone-bearing phenylalanine derivatives as novel HIV capsid modulators","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119307_bib44","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1039\/D3MD00134B","article-title":"Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators","volume":"14","author":"Zhang","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/v12040452","article-title":"Toward structurally novel and metabolically stable HIV-1 capsid-targeting small molecules","volume":"12","author":"Vernekar","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119307_bib46","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.3390\/molecules27185995","article-title":"Design, synthesis and structure-activity relationships of phenylalanine-containing peptidomimetics as novel HIV-1 capsid binders based on ugi four-component reaction","volume":"27","author":"Ji","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119307_bib47","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1021\/acs.jmedchem.4c01544","article-title":"\"Pseudosubstrate envelope\"\/free energy perturbation-guided design and mechanistic investigations of benzothiazole HIV capsid modulators with high ligand efficiency","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110500","article-title":"Breaking the impossible: the evolutionary journey of lenacapavir, a long-acting anti-HIV drug","volume":"36","author":"Tang","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119307_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","article-title":"Clinical targeting of HIV capsid protein with a long-acting small molecule","volume":"584","author":"Link","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119307_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.abb4808","article-title":"Structural and mechanistic bases for a potent HIV-1 capsid inhibitor","volume":"370","author":"Bester","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119307_bib51","doi-asserted-by":"crossref","first-page":"21072","DOI":"10.1021\/acs.jmedchem.5c01625","article-title":"Discovery of lenacapavir: first-in-class twice-yearly capsid inhibitor for HIV-1 treatment and pre-exposure prophylaxis","volume":"68","author":"Canales","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107009","article-title":"Lenacapavir: a novel injectable HIV-1 capsid inhibitor","volume":"63","author":"Hitchcock","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.119307_bib53","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1021\/acsmedchemlett.5c00405","article-title":"Delineating structural functionalities of Lenacapavir amenable to modifications for targeting emerging drug-resistant HIV-1 capsid variants","volume":"16","author":"Adu-Ampratwum","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119307_bib54","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1021\/acs.molpharmaceut.3c00626","article-title":"Lenacapavir: a novel, potent, and selective first-in-class inhibitor of HIV-1 capsid function exhibits optimal pharmacokinetic properties for a long-acting injectable antiretroviral agent","volume":"20","author":"Subramanian","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119307_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QCO.0000000000000896","article-title":"Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus","volume":"36","author":"Lee","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119307_bib56","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","article-title":"Twice-yearly Lenacapavir or daily F\/TAF for HIV prevention in cisgender women","volume":"391","author":"Bekker","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119307_bib57","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","article-title":"Twice-yearly Lenacapavir for HIV prevention in men and gender-diverse persons","volume":"392","author":"Kelley","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119307_bib58","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/S2352-3018(25)00128-6","article-title":"Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis","volume":"12","author":"van Zyl","year":"2025","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ejmech.2026.119307_bib59","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/jac\/dkaa060","article-title":"Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients","volume":"75","author":"Marcelin","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119307_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01804-22","article-title":"Structural and mechanistic bases of viral resistance to HIV-1 capsid inhibitor Lenacapavir","volume":"13","author":"Bester","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119307_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03613-24","article-title":"Structural and mechanistic bases for resistance of the M66I capsid variant to lenacapavir","volume":"16","author":"Briganti","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119307_bib62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/jac\/dkab503","article-title":"Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study","volume":"77","author":"Margot","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119307_bib63","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","article-title":"Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection","volume":"386","author":"Segal-Maurer","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119307_bib64","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/acs.jmedchem.2c01732","article-title":"Potent long-acting inhibitors targeting the HIV-1 capsid based on a versatile quinazolin-4-one scaffold","volume":"66","author":"Gillis","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib65","article-title":"Discovery of 4-quinazolinone-containing phenylalanine derivatives as potent, resistant-tolerant HIV capsid inhibitors","volume":"7","author":"Zhang","year":"2026","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2026.119307_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105926","article-title":"Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.119307_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01039-21","article-title":"A small molecule, ACAi-028, with anti-HIV-1 activity targets a novel hydrophobic pocket on HIV-1 capsid","volume":"65","author":"Chia","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119307_bib68","first-page":"383","article-title":"A molecular switch modulates assembly and host factor binding of the HIV-1 capsid","volume":"30","author":"Schirra","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119307_bib69","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1039\/D2RA06837K","article-title":"Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins","volume":"13","author":"Kobayakawa","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119307_bib70","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/s44321-024-00143-w","article-title":"A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import","volume":"16","author":"Boulay","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119307_bib71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.33696\/AIDS.7.068","article-title":"HIV-1 and artificial intelligence: from molecular insight to population impact","volume":"7","author":"Silvestri","year":"2025","journal-title":"J. AIDS HIV Treat."},{"key":"10.1016\/j.ejmech.2026.119307_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10822-022-00446-5","article-title":"Structure-based virtual screening workflow to identify antivirals targeting HIV-1 capsid","volume":"36","author":"Sun","year":"2022","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.119307_bib73","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41467-025-56317-8","article-title":"Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV","volume":"16","author":"Newton","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119307_bib74","article-title":"Twice-yearly Lenacapavir demonstrated exceptional efficacy for HIV prevention","volume":"5","author":"Xu","year":"2024","journal-title":"Innovation"},{"key":"10.1016\/j.ejmech.2026.119307_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00309-25","article-title":"Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499","volume":"69","author":"Wang","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119307_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/psp4.70254","article-title":"Pharmacokinetics, pharmacodynamics, efficacy and drug resistance selection of injectable long-acting lenacapavir pre-exposure prophylaxis (PrEP) against HIV","volume":"15","author":"Kim","year":"2026","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119307_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02539-7","article-title":"Antiviral drug discovery and development: challenges and future directions","volume":"11","author":"Du","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2026.119307_bib78","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.apsb.2025.03.013","article-title":"Editorial of virtual special issue: the development of antiviral drug discovery","volume":"15","author":"Du","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119307_bib79","doi-asserted-by":"crossref","first-page":"19929","DOI":"10.1021\/acs.jmedchem.4c02622","article-title":"Medicinal chemistry education: emphasize fundamentals and skillfully integrate knowledge","volume":"67","author":"Du","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib80","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cclet.2024.110456","article-title":"New techniques and strategies in drug discovery (2020\u20132024 update)","volume":"36","author":"Gong","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119307_bib81","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119307_bib82","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1016\/j.cell.2026.04.011","article-title":"Differential inhibition of morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization","volume":"189","author":"Xue","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119307_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110378","article-title":"Targeting novel sites represents an effective strategy for combating drug resistance","volume":"36","author":"Du","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119307_bib84","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.apsb.2026.02.007","article-title":"Cryptic pockets in proteins: harnessing conformational dynamics for rational drug design","volume":"16","author":"Ma","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119307_bib85","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1016\/j.apsb.2024.07.001","article-title":"Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119307_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101053","article-title":"Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges","volume":"73","author":"Du","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2026.119307_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2025.100094","article-title":"Conquering viral drug resistance: structural and mechanistic paradigms for antiresistance drug design","volume":"3","author":"Wang","year":"2025","journal-title":"Pharm. Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119307_bib88","first-page":"285","article-title":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality","volume":"2","author":"Zhou","year":"2023","journal-title":"Acta Mater. Med"},{"key":"10.1016\/j.ejmech.2026.119307_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118208","article-title":"Antiviral strategies based on targeted protein degradation: an overview of the literature and future outlook","volume":"301","author":"Zhou","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib90","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1007\/s11426-025-2658-0","article-title":"Harnessing molecular proximity for antiviral innovations: advances in proximity-inducing modalities against viral infections","volume":"68","author":"Wu","year":"2025","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib91","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1021\/acs.jmedchem.5c02312","article-title":"Anti-infective drug discovery: harnessing multimechanistic molecules and emergent properties to defeat pathogenic complexity","volume":"68","author":"Shi","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119307_bib92","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.apsb.2025.02.033","article-title":"Discovery and mechanism verification of first-in-class hydrophobic tagging-based degraders of HBV core protein","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600752X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600752X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:26:58Z","timestamp":1792643218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600752X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":92,"alternative-id":["S022352342600752X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119307","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided discovery of HIV-1 capsid inhibitors: From diverse binding sites to resistance-resilient antiviral strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119307"}}